Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 269

1.

Effect of AIT in children including potential to prevent the development of asthma.

Valovirta E.

Allergy. 2011 Jul;66 Suppl 95:53-4. doi: 10.1111/j.1398-9995.2011.02640.x.

2.

Design and recruitment for the GAP trial, investigating the preventive effect on asthma development of an SQ-standardized grass allergy immunotherapy tablet in children with grass pollen-induced allergic rhinoconjunctivitis.

Valovirta E, Berstad AK, de Blic J, Bufe A, Eng P, Halken S, Ojeda P, Roberts G, Tommerup L, Varga EM, Winnergard I; GAP investigators.

Clin Ther. 2011 Oct;33(10):1537-46. doi: 10.1016/j.clinthera.2011.09.013. Epub 2011 Oct 13.

PMID:
21999887
3.

Allergy immunotherapy tablet: Grazax® for the treatment of grass pollen allergy.

Senna GE, Calderon M, Milani M.

Expert Rev Clin Immunol. 2011 Jan;7(1):21-7. doi: 10.1586/eci.10.89.

PMID:
21162646
4.

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.

Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S.

J Allergy Clin Immunol. 2006 Apr;117(4):802-9.

PMID:
16630937
5.

Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.

Reich K, Gessner C, Kroker A, Schwab JA, Pohl W, Villesen H, Wüstenberg E, Emminger W.

Clin Ther. 2011 Jul;33(7):828-40. doi: 10.1016/j.clinthera.2011.06.006. Epub 2011 Jul 7.

PMID:
21741092
6.

Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy.

Bufe A, Eberle P, Franke-Beckmann E, Funck J, Kimmig M, Klimek L, Knecht R, Stephan V, Tholstrup B, Weisshaar C, Kaiser F.

J Allergy Clin Immunol. 2009 Jan;123(1):167-173.e7. doi: 10.1016/j.jaci.2008.10.044.

PMID:
19130937
7.
8.

[Sublingual immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis].

Wolthers OD, Høst A, Frederiksen B, Halken S.

Ugeskr Laeger. 2012 Aug 27;174(35):1989-92. Danish.

PMID:
22929576
9.
11.

Safety of specific sublingual immunotherapy with SQ standardized grass allergen tablets in children.

Ibañez MD, Kaiser F, Knecht R, Armentia A, Schöpfer H, Tholstrup B, Bufe A.

Pediatr Allergy Immunol. 2007 Sep;18(6):516-22.

PMID:
17680910
12.

Treatment of seasonal allergic rhinoconjunctivitis with a once-daily SQ-standardized grass allergy immunotherapy tablet.

Nelson H, Lehmann L, Blaiss MS.

Curr Med Res Opin. 2012 Jun;28(6):1043-51. doi: 10.1185/03007995.2012.684676. Epub 2012 May 9. Review.

PMID:
22502864
13.

Sublingual-swallow immunotherapy with standardized 3-grass pollen extract: a double-blind, placebo-controlled study.

de Blay F, Barnig C, Kanny G, Purohit A, Leynadier F, Tunon de Lara JM, Chabane H, Guérin L; SUBLIM Group.

Ann Allergy Asthma Immunol. 2007 Nov;99(5):453-61.

PMID:
18051216
14.

Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study.

Hordijk GJ, Antvelink JB, Luwema RA.

Allergol Immunopathol (Madr). 1998 Sep-Oct;26(5):234-40.

PMID:
9885731
15.

Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.

Roberts G, Hurley C, Turcanu V, Lack G.

J Allergy Clin Immunol. 2006 Feb;117(2):263-8.

PMID:
16461125
16.

Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.

Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz T, Braun W.

Allergy. 2004 May;59(5):498-504.

17.

Sustained effects of grass pollen AIT.

Durham SR; GT-08 investigators.

Allergy. 2011 Jul;66 Suppl 95:50-2. doi: 10.1111/j.1398-9995.2011.02639.x.

18.

A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen.

Rolinck-Werninghaus C, Wolf H, Liebke C, Baars JC, Lange J, Kopp MV, Hammermann J, Leupold W, Bartels P, Gruebl A, Bauer CP, Schnitker J, Wahn U, Niggemann B.

Allergy. 2004 Dec;59(12):1285-93.

19.

[Preventive immunotherapy].

Boquete M, Carballada F, Expósito F, González A.

Allergol Immunopathol (Madr). 2000 May-Jun;28(3):89-93. Review. Spanish.

PMID:
10867376
20.

Analysis of allergen immunotherapy studies shows increased clinical efficacy in highly symptomatic patients.

Howarth P, Malling HJ, Molimard M, Devillier P.

Allergy. 2012 Mar;67(3):321-7. doi: 10.1111/j.1398-9995.2011.02759.x. Epub 2011 Dec 6.

Supplemental Content

Support Center